These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 26647394)

  • 1. CCL5 derived from platelets increases megakaryocyte proplatelet formation.
    Machlus KR; Johnson KE; Kulenthirarajan R; Forward JA; Tippy MD; Soussou TS; El-Husayni SH; Wu SK; Wang S; Watnick RS; Italiano JE; Battinelli EM
    Blood; 2016 Feb; 127(7):921-6. PubMed ID: 26647394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCR5-Mediated Signaling Is Involved in Invasion of Glioblastoma Cells in Its Microenvironment.
    Novak M; Koprivnikar Krajnc M; Hrastar B; Breznik B; Majc B; Mlinar M; Rotter A; Porčnik A; Mlakar J; Stare K; Pestell RG; Lah Turnšek T
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer cell CCL5 mediates bone marrow independent angiogenesis in breast cancer.
    Sax MJ; Gasch C; Athota VR; Freeman R; Rasighaemi P; Westcott DE; Day CJ; Nikolic I; Elsworth B; Wei M; Rogers K; Swarbrick A; Mittal V; Pouliot N; Mellick AS
    Oncotarget; 2016 Dec; 7(51):85437-85449. PubMed ID: 27863423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Actin inhibition increases megakaryocyte proplatelet formation through an apoptosis-dependent mechanism.
    Avanzi MP; Izak M; Oluwadara OE; Mitchell WB
    PLoS One; 2015; 10(4):e0125057. PubMed ID: 25875470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CCL5/CCR5 Axis Promotes Vascular Smooth Muscle Cell Proliferation and Atherogenic Phenotype Switching.
    Lin CS; Hsieh PS; Hwang LL; Lee YH; Tsai SH; Tu YC; Hung YW; Liu CC; Chuang YP; Liao MT; Chien S; Tsai MC
    Cell Physiol Biochem; 2018; 47(2):707-720. PubMed ID: 29794461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune thrombocytopenia: antiplatelet autoantibodies inhibit proplatelet formation by megakaryocytes and impair platelet production in vitro.
    Iraqi M; Perdomo J; Yan F; Choi PY; Chong BH
    Haematologica; 2015 May; 100(5):623-32. PubMed ID: 25682608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Action of thrombopoietin at the megakaryocyte progenitor level is critical for the subsequent proplatelet production.
    Horie K; Miyazaki H; Hagiwara T; Tahara E; Matsumoto A; Kadoya T; Ogami K; Kato T
    Exp Hematol; 1997 Feb; 25(2):169-76. PubMed ID: 9015217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and dephosphorylation of MARCKS in the late stages of megakaryocyte maturation drive proplatelet formation.
    Machlus KR; Wu SK; Stumpo DJ; Soussou TS; Paul DS; Campbell RA; Kalwa H; Michel T; Bergmeier W; Weyrich AS; Blackshear PJ; Hartwig JH; Italiano JE
    Blood; 2016 Mar; 127(11):1468-80. PubMed ID: 26744461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCR5 antagonist treatment inhibits vascular injury by regulating NADPH oxidase 1.
    Singh S; Bruder-Nascimento A; Belin de Chantemele EJ; Bruder-Nascimento T
    Biochem Pharmacol; 2022 Jan; 195():114859. PubMed ID: 34843718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose dependent effects of platelet derived chondroitinsulfate A on the binding of CCL5 to endothelial cells.
    Weingart C; Nelson PJ; Krämer BK; Mack M
    BMC Immunol; 2008 Dec; 9():72. PubMed ID: 19068144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pivotal role of PDK1 in megakaryocyte cytoskeletal dynamics and polarization during platelet biogenesis.
    Geue S; Aurbach K; Manke MC; Manukjan G; Münzer P; Stegner D; Brähler C; Walker-Allgaier B; Märklin M; Borst CE; Quintanilla-Fend L; Rath D; Geisler T; Salih HR; Seizer P; Lang F; Nieswandt B; Gawaz M; Schulze H; Pleines I; Borst O
    Blood; 2019 Nov; 134(21):1847-1858. PubMed ID: 31578203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of CC Chemokine Receptor 5 with a Potent Chemokine Antagonist Reveals Mechanisms of Chemokine Recognition and Molecular Mimicry by HIV.
    Zheng Y; Han GW; Abagyan R; Wu B; Stevens RC; Cherezov V; Kufareva I; Handel TM
    Immunity; 2017 Jun; 46(6):1005-1017.e5. PubMed ID: 28636951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phospho-inositide-dependent kinase 1 regulates signal dependent translation in megakaryocytes and platelets.
    Manne BK; Bhatlekar S; Middleton EA; Weyrich AS; Borst O; Rondina MT
    J Thromb Haemost; 2020 May; 18(5):1183-1196. PubMed ID: 31997536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Actin reorganization and proplatelet formation in murine megakaryocytes: the role of protein kinase calpha.
    Rojnuckarin P; Kaushansky K
    Blood; 2001 Jan; 97(1):154-61. PubMed ID: 11133755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet formation is the consequence of caspase activation within megakaryocytes.
    De Botton S; Sabri S; Daugas E; Zermati Y; Guidotti JE; Hermine O; Kroemer G; Vainchenker W; Debili N
    Blood; 2002 Aug; 100(4):1310-7. PubMed ID: 12149212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of actin polymerization by tropomodulin-3 controls megakaryocyte actin organization and platelet biogenesis.
    Sui Z; Nowak RB; Sanada C; Halene S; Krause DS; Fowler VM
    Blood; 2015 Jul; 126(4):520-30. PubMed ID: 25964668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the CCL5 and Its Receptor, CCR5, in the Genesis of Aldosterone-Induced Hypertension, Vascular Dysfunction, and End-Organ Damage.
    Costa RM; Cerqueira DM; Bruder-Nascimento A; Alves JV; Awata WMC; Singh S; Kufner A; Prado DS; Johny E; Cifuentes-Pagano E; Hawse WF; Dutta P; Pagano PJ; Ho J; Bruder-Nascimento T
    Hypertension; 2024 Apr; 81(4):776-786. PubMed ID: 38240165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CR5/CCL5 axis is linked to a poor outcome, and inhibition reduces metastasis in oral squamous cell carcinoma.
    González-Arriagada WA; Coletta RD; Lozano-Burgos C; García C; Maripillán J; Alcayaga-Miranda F; Godínez-Pacheco B; Oyarce-Pezoa S; Martínez-Flores R; García IE
    J Cancer Res Clin Oncol; 2023 Dec; 149(19):17335-17346. PubMed ID: 37831273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin enhances megakaryopoiesis and proplatelet formation via p-Erk1/2 and F-actin reorganization.
    Ye JY; Liang EY; Cheng YS; Chan GC; Ding Y; Meng F; Ng MH; Chong BH; Lian Q; Yang M
    Stem Cells; 2014 Nov; 32(11):2973-82. PubMed ID: 24980849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCR5 antagonist blocks metastasis of basal breast cancer cells.
    Velasco-Velázquez M; Jiao X; De La Fuente M; Pestell TG; Ertel A; Lisanti MP; Pestell RG
    Cancer Res; 2012 Aug; 72(15):3839-50. PubMed ID: 22637726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.